These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32315465)

  • 41. Characterization and determination of cadmium resistance of CD133
    Shrestha S; Garrett SH; Sens DA; Zhou XD; Guyer R; Somji S
    Toxicol Appl Pharmacol; 2019 Jul; 375():5-16. PubMed ID: 31078587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma.
    Xu R; Cai MY; Luo RZ; Tian X; Han JD; Chen MK
    JAMA Dermatol; 2016 Mar; 152(3):305-11. PubMed ID: 26560495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell-Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1.
    Lee Y; Shin JH; Longmire M; Wang H; Kohrt HE; Chang HY; Sunwoo JB
    Clin Cancer Res; 2016 Jul; 22(14):3571-81. PubMed ID: 26864211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A possible interplay between HR-HPV and stemness in tumor development: an in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18-infected KB cell line.
    de Maria S; Santoro A; Fuggetta MP; Rocchetti R; Cottarelli A; Lanzilli G; Stiuso P; Angelico G; Spadola S; Franco Zannoni G; Rubini C; Emanuelli M; Carmela Pedicillo M; Pannone G; Muzio LL
    APMIS; 2020 Dec; 128(12):637-646. PubMed ID: 32911563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
    Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
    Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy.
    Dalley AJ; AbdulMajeed AA; Upton Z; Farah CS
    J Oral Pathol Med; 2013 Jan; 42(1):37-46. PubMed ID: 22643025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck.
    Okamoto A; Chikamatsu K; Sakakura K; Hatsushika K; Takahashi G; Masuyama K
    Oral Oncol; 2009 Jul; 45(7):633-9. PubMed ID: 19027347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells.
    Choi JI; Jang SI; Hong J; Kim CH; Kwon SS; Park JS; Lim JB
    Cancer Lett; 2021 Feb; 498():42-53. PubMed ID: 33188841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adipose-derived stem cells and cancer cells fuse to generate cancer stem cell-like cells with increased tumorigenicity.
    Chan YW; So C; Yau KL; Chiu KC; Wang X; Chan FL; Tsang SY
    J Cell Physiol; 2020 Oct; 235(10):6794-6807. PubMed ID: 31994190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro characterization of CD133
    Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
    BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
    Nakshatri H; Srour EF; Badve S
    Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and biological significance of stem-like CD133(+)CXCR4(+) cells in esophageal squamous cell carcinoma.
    Lu C; Xu F; Gu J; Yuan Y; Zhao G; Yu X; Ge D
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):386-95. PubMed ID: 26092504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
    Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
    Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of cell dissociation on identification of breast cancer stem cells.
    Quan Y; Yan Y; Wang X; Fu Q; Wang W; Wu J; Yang G; Ren J; Wang Y
    Cancer Biomark; 2012-2013; 12(3):125-33. PubMed ID: 23481571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topotecan-induced ABCG2 expression in MCF-7 cells is associated with decreased CD24 and EpCAM expression and a loss of tumorigenicity.
    Huber S; Wege AK; Bernhardt G; Buschauer A; Brockhoff G
    Cytometry A; 2015 Aug; 87(8):707-16. PubMed ID: 25892097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD44+ cancer cell-induced metastasis: A feasible neck metastasis model.
    Wu TF; Chen L; Bu LL; Gao J; Zhang WF; Jia J
    Eur J Pharm Sci; 2017 Apr; 101():243-250. PubMed ID: 28215944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
    Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
    Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma.
    Park E; Park SY; Sun PL; Jin Y; Kim JE; Jheon S; Kim K; Lee CT; Kim H; Chung JH
    Oncotarget; 2016 Jul; 7(27):42502-42512. PubMed ID: 27285762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
    Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
    Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single Amino Acid Variant Profiles of Subpopulations in the MCF-7 Breast Cancer Cell Line.
    Tan Z; Nie S; McDermott SP; Wicha MS; Lubman DM
    J Proteome Res; 2017 Feb; 16(2):842-851. PubMed ID: 28076950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.